SA Pharmaceutical Journal - Volume 77, Issue 8, 2010
Volume 77, Issue 8, 2010
Author Lorraine OsmanSource: SA Pharmaceutical Journal 77 (2010)More Less
Reflection on accusations
I was recently accused of not using "Piece of my mind" to share with you my thoughts on subjects related to the running of the Pharmacy Council. In particular, I guess, for not sharing with you my thoughts on problems that pharmacists have encountered when they want something from Pharmacy Council.
Source: SA Pharmaceutical Journal 77, pp 8 –9 (2010)More Less
At its AGM earlier this year, the PSSA bestowed Honorary Life Membership on Cecil Abramson and Benzie Joffe for the contributions that they have made to the PSSA and to the profession. In August, they received the Award at a dinner hosted by the Southern Gauteng branch of the PSSA.
Source: SA Pharmaceutical Journal 77 (2010)More Less
The Pharmacy Stakeholders Forum (PSF) welcomed the publication of the draft dispensing fee for pharmacists. It follows many months of research and discussion, and many years of frustration.
Draft regulations for comment were originally published in January 2004, and have been unsuccessfully revised a number of times. In 2005, the Constitutional Court instructed the Pricing Committee to take into consideration input given by interested parties, and to ensure that the final dispensing fee is just and equitable. This was considered essential so that pharmacies would not be driven out of business.
Author Angelene Van der WesthuizenSource: SA Pharmaceutical Journal 77, pp 10 –20 (2010)More Less
Attention-deficit / hyperactivity disorder (ADHD) is one of the most common childhood psychiatric conditions. The core symptoms of ADHD are hyperactivity, impulsivity and / or inattention. These symptoms can lead to problems in academic achievement, behaviour, personal relationships with family and peers and low self-esteem. Symptoms first present in childhood and can continue through adolescence into adulthood. Co-morbid disorders include oppositional defiant disorder, conduct disorder, anxiety, depression, tics and Tourette's syndrome, and epilepsy. Stimulants are first-line in the pharmacological treatment of ADHD. Methylphenidate is the most common drug prescribed in this condition. Pharmacological treatment should form part of a comprehensive treatment plan which should include psychological, educational and social measures assessed on an individual basis.
Author Shirra MochSource: SA Pharmaceutical Journal 77, pp 22 –33 (2010)More Less
This article explores the clinical and therapeutic differences between major depressive disorder and bipolar depression. Although both are disorders of suppressed mood with similar symptoms, the two syndromes respond differently to medications : Whereas severe major depressive disorder responds to antidepressant medication, either as monotherapy or in combination, there is some evidence that in bipolar depression of all subtypes, response to antidepressants is no greater than to placebo. Quetiapine, lamotrigine, lithium or olanzapine are recommended initially, with antidepressant usage included in combination therapy only at later stages of management. Further research is necessary to determine pathophysiological differences between these two disorders and ideal treatment approaches.
The process of analysing, assessing, managing and communicating drug-interaction risks has become a priority in 2010 : advertorialSource: SA Pharmaceutical Journal 77 (2010)More Less
Author Catherine WhittakerSource: SA Pharmaceutical Journal 77, pp 34 –42 (2010)More Less
Allergic rhinitis, sometimes referred to as "hay fever", is an extremely common condition. It can significantly impair quality of life and may impact on work or school performance and attendance. Many patients seek the advice of a pharmacist regarding the prevention and management of allergic rhinitis. There are many preventative measures and therapeutic approaches that can be recommended in order to provide affected individuals with rapid and sustained symptomatic relief.
Author Jacqui SouterSource: SA Pharmaceutical Journal 77, pp 44 –60 (2010)More Less
Meningitis is an inflammatory disease of the meninges covering the brain. Bacteria, viruses, fungi, chemicals or inflammatory conditions are some of the potential causes of meningitis. In this article, we discuss prevention of the three most common bacterial causes of meningitis: Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae.
Source: SA Pharmaceutical Journal 77, pp 48 –53 (2010)More Less
Many conditions within the oral cavity require the use of a mouthwash. This can vary from breath fresheners to treatment of life threatening secondary infections such as oral mucositis in patients undergoing bone marrow transplant therapy. The use of mouthwashes requires a correct diagnosis of the oral condition and a thorough knowledge of the product in question to achieve effective treatment. It is the objective of this review to help health care workers in South Africa make the correct choice of treatment when dealing with diverse conditions of the oral cavity.
Strategies to improve blood pressure control and cardiovascular outcomes in hypertensive patients : medfileSource: SA Pharmaceutical Journal 77, pp 54 –60 (2010)More Less
Hypertension is a major contributor to cardiovascular morbidity and mortality. However, blood pressure control in clinical practice still falls short of treatment recommendations. The reasons for this are manifold and patient noncompliance with medication has been identified as one important factor.
In this article we discuss the various reasons for patient noncompliance and look at strategies to improve adherence, for example simplifying the medication regimen and reducing side effects in an asymptomatic disease such as hypertension. In this regard, combination treatment, and specifically fixed-dose combinations, has come a long way in enhancing tolerability, reducing counter-regulatory drug mechanisms and bringing blood pressure closer to target.
Furthermore, we investigate the possibility of some combinations having clinical benefits beyond blood pressure control, as this may improve long-term cardiovascular outcomes. On the other hand, certain combinations may only have positive clinical outcomes in carefully selected patient groups and are not recommended for routine management of hypertension.
Lastly, issues such as escape mechanisms in the renin angiotensin aldosterone system (RAAS) are discussed - these mechanisms play a role in treatment failure and may require the use of new antihypertensive drug classes, such as direct renin inhibitors.
Author Henry M.J. LengSource: SA Pharmaceutical Journal 77 (2010)More Less
September, as we all know, is the most important month in the calendar of the Academy. It is of course the month in which we hold our annual congress. Congresses are important since they bring together, in one location, present and future leaders of a research field or discipline. Speakers are assured of a captive audience since all have the same or similar interest.
Source: SA Pharmaceutical Journal 77 (2010)More Less
In the June 2010 issue of the SAPJ, the postgraduate degrees in the Pharmaceutical Sciences awarded by a number of universities were listed. This month, those awarded by the Tshwane University of Technology and the University of Limpopo (Medunsa campus) are recognised.
To VAT or not to VAT - a suggestion to help medical schemes and NHI implementation : pharmaceutical practitionerAuthor Johann KrugerSource: SA Pharmaceutical Journal 77 (2010)More Less
English is a strange language. Before the introduction of Value Added Tax (VAT), we had never heard the word "vatable". Even nowadays, we don't use the word easily in casual conversation. It's one of those new words that was thought up to use as an adjective, and it simply describes goods or services on which VAT must be paid.